An <scp>ACE2</scp> decoy can be administered by inhalation and potently targets omicron variants of <scp>SARS‐CoV</scp> ‐2-Reference-Cited by-同舟云学术

An ACE2 decoy can be administered by inhalation and potently targets omicron variants of SARS‐CoV ‐2

Published:2022-09-23 Issue:11 Volume:14 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Zhang Lianghui¹^ORCID,Narayanan Krishna K²^ORCID,Cooper Laura³^ORCID,Chan Kui K⁴,Skeeters Savanna S⁴,Devlin Christine A²^ORCID,Aguhob Aaron⁴,Shirley Kristie⁴,Rong Lijun³^ORCID,Rehman Jalees¹⁵^ORCID,Malik Asrar B¹^ORCID,Procko Erik²⁴^ORCID

Affiliation:

1. Department of Pharmacology and Regenerative Medicine and the Center for Lung and Vascular Biology The University of Illinois College of Medicine Chicago IL USA

2. Department of Biochemistry University of Illinois Urbana IL USA

3. Department of Microbiology and Immunology The University of Illinois College of Medicine Chicago IL USA

4. Cyrus Biotechnology, Inc. Seattle WA USA

5. Department of Biochemistry and Molecular Genetics The University of Illinois College of Medicine Chicago IL USA

Funder

National Heart, Lung, and Blood Institute

National Institute of Allergy and Infectious Diseases

Publisher

EMBO

Subject

Molecular Medicine

Link